CIK: 0001582844
Total reported value
$141.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IMMU | Immunomedics INC | Stock-Other | 11.81% | — | -6.15% | |
| 2 | KURA | Kura Oncology INC | Stock-Other | 8.10% | — | +11.52% | |
| 3 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 7.57% | — | — | |
| 4 | CLDX | Celldex Therapeutics INC | Stock-Other | 6.22% | — | +54.50% | |
| 5 | SG7 | Sage Therapeutics INC | Stock-Other | 3.73% | — | — | |
| 6 | CMPS | Compass Pathways PLC | Stock-Other | 3.70% | — | — | |
| 7 | LRMR | Larimar Therapeutics INC | Stock-Other | 3.42% | — | +0.83% | |
| 8 | ✓ | Mersana Therapeutics INC | Stock-Other | 3.38% | — | +5.53% | |
| 9 | ALDX | Aldeyra Therapeutics INC | Stock-Other | 3.31% | — | +85.02% | |
| 10 | TREUR | Trillium Therapeutics INC | Stock-Other | 3.29% | — | — | |
| 11 | ETNBGBP | 89bio INC | Stock-Other | 2.91% | — | — | |
| 12 | RLMD | Relmada Therapeutics INC | Stock-Other | 2.83% | — | +18.12% | |
| 13 | IOVA | Iovance Biotherapeutics INC | Stock-Other | 2.82% | — | -46.61% | |
| 14 | ALT | Altimmune INC | Stock-Other | 2.47% | — | +28.00% | |
| 15 | IMVT | Immunovant INC | Stock-Other | 2.39% | — | -28.57% | |
| 16 | CYTK | Cytokinetics INC | Stock-Healthcare | 2.10% | — | — | |
| 17 | ✓ | Rapt Therapeutics INC | Stock-Other | 2.10% | — | — | |
| 18 | ✓ | Lifesci Acquisition CORP | Stock-Other | 2.07% | — | — | |
| 19 | SURFUSD | Surface Oncology INC | Stock-Other | 2.04% | — | +383.56% | |
| 20 | ✓ | Athira Pharma INC | Stock-Other | 1.82% | — | — | |
| 21 | RNAGBP | Avidity Biosciences INC | Stock-Other | 1.80% | — | +100.00% | |
| 22 | ✓ | Gyre Therapeutics INC Com | Stock-Other | 1.75% | — | — | |
| 23 | SELBUSD | Cartesian Therapeutics INC | Stock-Other | 1.59% | — | — | |
| 24 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 1.50% | — | — | |
| 25 | APLSUSD | Apellis Pharmaceuticals INC | Stock-Other | 1.37% | — | -12.08% | |
| 26 | OPHTEUR | Iveric Bio INC | Stock-Other | 1.23% | — | +16.73% | |
| 27 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 1.19% | — | +69.17% | |
| 28 | CRDF | Cardiff Oncology INC | Stock-Other | 1.18% | — | -24.93% | |
| 29 | ✓ | Health Sciences Acq CORP 2 | Stock-Other | 1.17% | — | — | |
| 30 | ✓ | Avadel Pharmaceuticals PLC | Stock-Other | 0.97% | — | -59.75% | |
| 31 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 0.96% | — | — | |
| 32 | ✓ | Panacea Acquisition CORP | Stock-Other | 0.91% | — | — | |
| 33 | ANNX | Annexon INC | Stock-Other | 0.90% | — | — | |
| 34 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.90% | — | -42.03% | |
| 35 | FULC | Fulcrum Therapeutics INC | Stock-Other | 0.82% | — | — | |
| 36 | CNCEEUR | Concert Pharmaceuticals INC | Stock-Other | 0.80% | — | — | |
| 37 | ✓ | Veralto CORP | Stock-Other | 0.79% | — | -9.43% | |
| 38 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 0.62% | — | -65.26% | |
| 39 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 0.44% | — | -75.00% | |
| 40 | ✓ | Stock-Other | 0.28% | — | -82.69% | ||
| 41 | ✓ | Unum Therapeutics INC | Stock-Other | 0.26% | — | — | |
| 42 | CLSDUSD | Clearside Biomedical INC | Stock-Other | 0.26% | — | — | |
| 43 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.25% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IMMU | Immunomedics INC | +6.2% | -6.15% | Trim |
| 2 | KURA | Kura Oncology INC | +4% | +11.52% | Add |
| 3 | CLDX | Celldex Therapeutics INC | +2.5% | +54.50% | Add |
| 4 | ALDX | Aldeyra Therapeutics INC | +2.2% | +85.02% | Add |
| 5 | SURFUSD | Surface Oncology INC | +1.6% | +383.56% | Add |
| 6 | RNAGBP | Avidity Biosciences INC | +0.8% | +100.00% | Add |
| 7 | ALT | Altimmune INC | +0.8% | +28.00% | Add |
| 8 | CRDF | Cardiff Oncology INC | +0.6% | -24.93% | Trim |
| 9 | LRMR | Larimar Therapeutics INC | +0.5% | +0.83% | Add |
| 10 | ARWR | Arrowhead Pharmaceuticals In | +0.4% | +69.17% | Add |
| 11 | ✓ | Veralto CORP | -0.5% | -9.43% | Trim |
| 12 | ✓ | Gyre Therapeutics INC Com | -0.8% | — | Unchanged |
| 13 | ✓ | Mersana Therapeutics INC | -0.9% | +5.53% | Add |
| 14 | XENE | Xenon Pharmaceuticals INC | -1% | -42.03% | Trim |
| 15 | AXSM | Axsome Therapeutics INC | -1.7% | -75.00% | Trim |
| 16 | IOVA | Iovance Biotherapeutics INC | -1.9% | -46.61% | Trim |
| 17 | BCRX | Biocryst Pharmaceuticals INC | -2% | -65.26% | Trim |
| 18 | ✓ | -2.2% | -82.69% | Trim | |
| 19 | ✓ | Avadel Pharmaceuticals PLC | -3.1% | -59.75% | Trim |
| 20 | ADVMCHF | Adverum Biotechnologies INC | — | EXIT | Sold out |
| 21 | XBI | Ss Spdr S&p Biotech ETF | — | NEW | New buy |
| 22 | BTAIEUR | Bioxcel Therapeutics INC | — | EXIT | Sold out |
| 23 | SG7 | Sage Therapeutics INC | — | NEW | New buy |
| 24 | CMPS | Compass Pathways PLC | — | NEW | New buy |
| 25 | TREUR | Trillium Therapeutics INC | — | NEW | New buy |
| 26 | ADAPY | Adaptimmune Therapeutics-adr | — | EXIT | Sold out |
| 27 | ETNBGBP | 89bio INC | — | NEW | New buy |
| 28 | ASND | Ascendis Pharma A/S | — | EXIT | Sold out |
| 29 | BLU | Bellus Health INC | — | EXIT | Sold out |
| 30 | CYTK | Cytokinetics INC | — | NEW | New buy |
| 31 | ✓ | Rapt Therapeutics INC | — | NEW | New buy |
| 32 | ✓ | Merus N V | — | EXIT | Sold out |
| 33 | ✓ | Athira Pharma INC | — | NEW | New buy |
| 34 | APLT | Applied Therapeutics INC | — | EXIT | Sold out |
| 35 | KDMN | Kadmon Holdings INC | — | EXIT | Sold out |
| 36 | CBAYUSD | Cymabay Therapeutics INC | — | NEW | New buy |
| 37 | VIR | Vir Biotechnology INC | — | EXIT | Sold out |
| 38 | ✓ | Health Sciences Acq CORP 2 | — | NEW | New buy |
| 39 | DRNAUSD | Dicerna Pharmaceuticals INC | — | EXIT | Sold out |
| 40 | ARVN | Arvinas INC | — | EXIT | Sold out |
| 41 | AGENEUR | Agenus INC | — | EXIT | Sold out |
| 42 | ✓ | Panacea Acquisition CORP | — | NEW | New buy |
| 43 | ANNX | Annexon INC | — | NEW | New buy |
| 44 | FULC | Fulcrum Therapeutics INC | — | NEW | New buy |
| 45 | CNCEEUR | Concert Pharmaceuticals INC | — | NEW | New buy |
| 46 | CLDNEUR | Eiger Biopharmaceuticals INC | — | EXIT | Sold out |
| 47 | QURE | uniQure N.V. | — | EXIT | Sold out |
| 48 | RETAEUR | Reata Pharmaceuticals Inc-a | — | EXIT | Sold out |
| 49 | ✓ | Fusion Pharmaceuticals INC | — | EXIT | Sold out |
| 50 | GBIOGBX | Generation Bio Co | — | EXIT | Sold out |